- 144 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
Epigenetic Regulation in Overcoming Chemoresistance
About this book
Epigenetic Regulation in Overcoming Chemoresistance, Volume 19, explains how epigenetic agents can enhance the chemotherapy sensitivity of diverse types of cancers. The book provides a comprehensive delineation and the recent development of the scientific studies on the epigenetic regulation in enhancing chemo-sensitivity. In addition, it discusses several topics such as DNA methyltransferase inhibitors (DNMTi), Histone deacetylases inhibitors (HDACi), Histone lysine demethylases inhibitors (HDMi), Histone lysine methyltransferases inhibitors (HMTi) and drugs regulating the microRNA, long non-coding RNA (lncRNA) or RNA methylation. Finally, recent and future developments of the field of epigenetic regulation are explored.
This is a valuable resource for cancer researchers, clinicians, graduate students and several members of biomedical field who are interested in learning about epigenetic regulation methods to reverse chemo-resistance in cancers.
- Presents detailed diagrams of the mechanisms of epigenetic regulation for easy consult
- Encompasses multiple clinical trial summary diagrams to help readers quickly and clearly get information from clinical trials
- Provides future perspectives in each section to inspire readers to use epigenetic regulation to overcome chemo-resistance
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Epigenetic Regulation in Overcoming Chemoresistance by Chunfu Wu,Lihui Wang in PDF and/or ePUB format, as well as other popular books in Biological Sciences & Biology. We have over one million books available in our catalogue for you to explore.
Information
Table of contents
- Epigenetic Regulation in Overcoming Chemoresistance
- Cover
- Title Page
- Copyright
- Table of Contents
- Cover Image Insert
- Aims and Scope for Series “Cancer Sensitizing Agents for Chemotherapy”
- About the Series Editor
- Aims and Scope of the Volume
- About the Volume Editors
- Preface
- Contributors
- Chapter 1 The role of epigenetic regulation in cancer
- Chapter 2 DNA methyltransferase inhibitors (DNMTis) as sensitizing agents to overcome chemoresistance
- Chapter 3 Histone deacetylase inhibitors (HDACi), the ongoing epigenetic agents to enhance chemotherapy sensitization
- Chapter 4 Histone lysine demethylase inhibitor (HDMi) as chemo-sensitizing agent
- Chapter 5 Targeting histone lysine methyltransferases for drug sensitization
- Chapter 6 Ribonucleotide base-modifying enzymes and diseases
- Chapter 7 The combination strategy with epigenetic therapy, chemotherapy, and immunotherapy
- Chapter 8 Future epigenetic treatment strategies
- Index